Intellia Therapeutics Inc (NTLA) Dividend History
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and Virginijus Šikšnys . The company has partnerships with Novartis and Regeneron. Intellia Therapeutics was founded in May 2014 to develop biopharmaceuticals using CRISPR.
Last update 01/22/2022
Dividend Yield Summary
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 17.34 | 24.12 | 15.12 | 21.99 | 105.98 | 103.43 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |